Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats

Abstract Gadolinium based contrast agents (GBCAs) are widely used in clinical MRI since the mid-1980s. Recently, concerns have been raised that trace amounts of Gadolinium (Gd), detected in brains even long time after GBCA application, may cause yet unrecognized clinical consequences. We therefore a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johanna Habermeyer, Janina Boyken, Julia Harrer, Fabio Canneva, Veronika Ratz, Sandra Moceri, Jakob Admard, Nicolas Casadei, Gregor Jost, Tobias Bäuerle, Thomas Frenzel, Christoph Schmitz, Gunnar Schütz, Hubertus Pietsch, Stephan von Hörsten
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/475697f1def341ca8d5a1b8ad2c58eaf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:475697f1def341ca8d5a1b8ad2c58eaf
record_format dspace
spelling oai:doaj.org-article:475697f1def341ca8d5a1b8ad2c58eaf2021-12-02T14:01:28ZComprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats10.1038/s41598-020-79374-z2045-2322https://doaj.org/article/475697f1def341ca8d5a1b8ad2c58eaf2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79374-zhttps://doaj.org/toc/2045-2322Abstract Gadolinium based contrast agents (GBCAs) are widely used in clinical MRI since the mid-1980s. Recently, concerns have been raised that trace amounts of Gadolinium (Gd), detected in brains even long time after GBCA application, may cause yet unrecognized clinical consequences. We therefore assessed the behavioral phenotype, neuro-histopathology, and Gd localization after repeated administration of linear (gadodiamide) or macrocyclic (gadobutrol) GBCA in rats. While most behavioral tests revealed no difference between treatment groups, we observed a transient and reversible decrease of the startle reflex after gadodiamide application. Residual Gd in the lateral cerebellar nucleus was neither associated with a general gene expression pathway deregulation nor with neuronal cell loss, but in gadodiamide-treated rats Gd was associated with the perineuronal net protein aggrecan and segregated to high molecular weight fractions. Our behavioral finding together with Gd distribution and speciation support a substance class difference for Gd presence in the brain after GBCA application.Johanna HabermeyerJanina BoykenJulia HarrerFabio CannevaVeronika RatzSandra MoceriJakob AdmardNicolas CasadeiGregor JostTobias BäuerleThomas FrenzelChristoph SchmitzGunnar SchützHubertus PietschStephan von HörstenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Johanna Habermeyer
Janina Boyken
Julia Harrer
Fabio Canneva
Veronika Ratz
Sandra Moceri
Jakob Admard
Nicolas Casadei
Gregor Jost
Tobias Bäuerle
Thomas Frenzel
Christoph Schmitz
Gunnar Schütz
Hubertus Pietsch
Stephan von Hörsten
Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
description Abstract Gadolinium based contrast agents (GBCAs) are widely used in clinical MRI since the mid-1980s. Recently, concerns have been raised that trace amounts of Gadolinium (Gd), detected in brains even long time after GBCA application, may cause yet unrecognized clinical consequences. We therefore assessed the behavioral phenotype, neuro-histopathology, and Gd localization after repeated administration of linear (gadodiamide) or macrocyclic (gadobutrol) GBCA in rats. While most behavioral tests revealed no difference between treatment groups, we observed a transient and reversible decrease of the startle reflex after gadodiamide application. Residual Gd in the lateral cerebellar nucleus was neither associated with a general gene expression pathway deregulation nor with neuronal cell loss, but in gadodiamide-treated rats Gd was associated with the perineuronal net protein aggrecan and segregated to high molecular weight fractions. Our behavioral finding together with Gd distribution and speciation support a substance class difference for Gd presence in the brain after GBCA application.
format article
author Johanna Habermeyer
Janina Boyken
Julia Harrer
Fabio Canneva
Veronika Ratz
Sandra Moceri
Jakob Admard
Nicolas Casadei
Gregor Jost
Tobias Bäuerle
Thomas Frenzel
Christoph Schmitz
Gunnar Schütz
Hubertus Pietsch
Stephan von Hörsten
author_facet Johanna Habermeyer
Janina Boyken
Julia Harrer
Fabio Canneva
Veronika Ratz
Sandra Moceri
Jakob Admard
Nicolas Casadei
Gregor Jost
Tobias Bäuerle
Thomas Frenzel
Christoph Schmitz
Gunnar Schütz
Hubertus Pietsch
Stephan von Hörsten
author_sort Johanna Habermeyer
title Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
title_short Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
title_full Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
title_fullStr Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
title_full_unstemmed Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
title_sort comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/475697f1def341ca8d5a1b8ad2c58eaf
work_keys_str_mv AT johannahabermeyer comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT janinaboyken comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT juliaharrer comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT fabiocanneva comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT veronikaratz comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT sandramoceri comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT jakobadmard comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT nicolascasadei comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT gregorjost comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT tobiasbauerle comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT thomasfrenzel comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT christophschmitz comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT gunnarschutz comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT hubertuspietsch comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
AT stephanvonhorsten comprehensivephenotypingrevealedtransientstartleresponsereductionandhistopathologicalgadoliniumlocalizationtoperineuronalnetsaftergadodiamideadministrationinrats
_version_ 1718392138595565568